| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/10/2002 | CN1358089A Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same |
| 07/10/2002 | CN1358088A Pharmaceuticla dosage forms for controlled telease producing at least timed pulse |
| 07/10/2002 | CN1358087A Timed dual release dosage forms comprising short acting hypnotic or salt thereof |
| 07/10/2002 | CN1358086A Ophthalmic composition comprising retotifen |
| 07/10/2002 | CN1358063A Effervescent green tea extract formulation |
| 07/10/2002 | CN1357618A Biological bacteriophagic Bdellovibrio prepn and its production process |
| 07/10/2002 | CN1357407A Conjugate linoleic acid or conjugate linoleate microcapsule |
| 07/10/2002 | CN1357387A Foot refreshing powder |
| 07/10/2002 | CN1357381A Dressed medicine for treating hernia |
| 07/10/2002 | CN1357376A Chinese medicine capable of being taken orally after being decocted or mixed with boiling water or directly and being applied externally |
| 07/10/2002 | CN1357369A Externally applied ointment for treating burns, wound and frost bite and its prepn |
| 07/10/2002 | CN1357363A Malian granule for clearing away liver fire |
| 07/10/2002 | CN1357358A Blood circulation activating and pain stopping ointment for treating bone injury and its prepn process |
| 07/10/2002 | CN1357338A Hyperosteogeny treating plaster |
| 07/10/2002 | CN1357334A Artificial bear bile powder |
| 07/10/2002 | CN1357320A Taurine chewing gum and its making process |
| 07/10/2002 | CN1357319A Production process of Muli aloe leaf powder |
| 07/10/2002 | CN1357318A Prepn process, product and use of nano Chinese medicine pieces |
| 07/10/2002 | CN1357317A Prepn of superfine Se particle |
| 07/10/2002 | CN1087317C Block polymer having functional groups at both ends |
| 07/10/2002 | CN1087185C Process and apparatus for agglomeration of hydrolytically sensitive substances by means of steam |
| 07/10/2002 | CN1087178C Isotopic urea tablets |
| 07/10/2002 | CN1087176C Vaccine compositions containing 3-O deacylated monophosphoryl lipid A |
| 07/10/2002 | CN1087169C Anti-inflammatory eyedrops |
| 07/09/2002 | US6417365 Recovering drugs from discarded transdermal devices; adding acid or basic aqueous extraction liquid to laminate; agitation; precipitating active substance |
| 07/09/2002 | US6417326 Fusogenic liposomes |
| 07/09/2002 | US6417237 Macromolecular drug complexes and compositions containing the same |
| 07/09/2002 | US6417228 Treatment of glaucoma and hypotensive agents |
| 07/09/2002 | US6417227 Methods of delivery of cetyl myristoleate |
| 07/09/2002 | US6417196 Stabilization of quinapril using magnesium oxide |
| 07/09/2002 | US6417179 Ear wax solution |
| 07/09/2002 | US6417173 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 07/09/2002 | US6417172 Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs |
| 07/09/2002 | US6417170 Administering to skin a composition containing deoxyribonucleosides in concentrations sufficient to enhance dna repair or reduce mutation frequency in a vehicle capable of delivering deoxyribonucleosides to skin cells |
| 07/09/2002 | US6417167 Lyophilized compositions containing shingoglycolipid and process for preparing them |
| 07/09/2002 | US6416799 Encapsulation compositions |
| 07/09/2002 | US6416793 Adding solubilizing emulsifier, adding solvent and surfactant, dissolving one or more phytochemicals, adding encapsulator, mixing to produce microdispersion, spray drying |
| 07/09/2002 | US6416790 Bactericidal concentrate and method for treating burns and dermal lesions |
| 07/09/2002 | US6416787 Extruding, at elevated temperature, a composition comprising a starch, water, a thermostable enzyme, and a drug; the porous extrudate is capable of disintegration when exposed to an aqueous environment. |
| 07/09/2002 | US6416786 Sustained release tablet containing hydrocolloid and cellulose ether |
| 07/09/2002 | US6416781 Device for releasing with delayed effect an active substance, in particular veterinary |
| 07/09/2002 | US6416780 Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors |
| 07/09/2002 | US6416779 Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections |
| 07/09/2002 | US6416778 Pharmaceutical preparations and methods for their regional administration |
| 07/09/2002 | US6416777 Ophthalmic drug delivery device |
| 07/09/2002 | US6416774 Hollow bone mineral-like calcium phosphate particles |
| 07/09/2002 | US6416772 Comprising an alcohol, glycerin, an analgesic agent comprising salicylic acid, methylsulfonylmethane, emu oil |
| 07/09/2002 | US6416767 Use of peroxidized lipids as agents intended to prevent and/or to treat the irritant effects of an active principle |
| 07/09/2002 | US6416749 Treatment for onychomycosis topically applying salicylic acid, optionally in combination with a retinoid |
| 07/09/2002 | US6416745 Comprised of diolylphosphatidic acid liposomes capable of inducing mineral formation in dentinal tubules and desensitizing agents |
| 07/09/2002 | US6416744 Tooth whitening chewing gum |
| 07/09/2002 | US6416743 Nontoxic, stable formulation free of chlorofluorocarbons; surfactant and excipient free |
| 07/09/2002 | US6416742 Medicinal aerosol solution formulation with biocompatible polymer |
| 07/09/2002 | US6416741 Preparation of further diagnostic agents |
| 07/09/2002 | US6416740 Acoustically active drug delivery systems |
| 07/09/2002 | US6416739 Microparticles and their therapeutic or diagnostic use |
| 07/09/2002 | US6416510 Drug delivery catheters that attach to tissue and methods for their use |
| 07/09/2002 | US6415992 Spray device containing nitrogen-carbon dioxide propellent gas mixture |
| 07/09/2002 | CA2367232A1 Topical compositions for active wound healing with decreased scarring |
| 07/09/2002 | CA2303132C Intranasal formulations containing scopolamine and method of treating motion sickness |
| 07/09/2002 | CA2273420C Matrix tablet permitting sustained release of gliclazide after oral administration |
| 07/09/2002 | CA2219475C Pharmaceutical composition of fenofibrate presenting a high biodisponibility and its preparation process |
| 07/09/2002 | CA2132210C Oil-in-water emulsions of positively charged particles |
| 07/09/2002 | CA2117763C Supersaturated topical composition |
| 07/09/2002 | CA2061566C Treatment of disease employing hyaluronic acid and nsaids |
| 07/09/2002 | CA2053468C Prolonged release preparation and polymers thereof |
| 07/09/2002 | CA2026763C Cosmetic or pharmaceutical composition for topical use, comprising at least one retinoid derivation and at least one pyrimidine derivative, use of same for medical purpose, and method of using same |
| 07/09/2002 | CA2024916C Respiratory disorder medicaments comprising salmeterol and fluticasone propionate |
| 07/08/2002 | CA2366780A1 Stabilized liquid preparation of the protease which activates blood coagulation factor vii, or of its proenzyme |
| 07/04/2002 | WO2002051800A2 Sulphur-containing amphiphilic agents for the transfer of biologically active molecules into cells |
| 07/04/2002 | WO2002051536A1 Encapsulation of emulsions |
| 07/04/2002 | WO2002051535A2 Preparation of microparticles having improved flowability |
| 07/04/2002 | WO2002051483A1 Metered dose inhaler for salmeterol xinafoate |
| 07/04/2002 | WO2002051460A2 Bioactive materials for aneurysm repair |
| 07/04/2002 | WO2002051452A1 Process to improve stability of a pharmaceutical composition |
| 07/04/2002 | WO2002051443A2 Aqueous gel comprising a gelling agent such as kappa carrageenan and at least 85 % water |
| 07/04/2002 | WO2002051436A2 Stable enzymatic wound debrider |
| 07/04/2002 | WO2002051427A1 Improved and stable extract from hypericum perforatum l., method for the production thereof and its use as a topical medicament |
| 07/04/2002 | WO2002051426A2 Compositions and methods for treating sexual dysfunction, enhancing sexual function, increasing testosterone levels, and improving muscle strength and mass |
| 07/04/2002 | WO2002051421A2 Gel composition and trans-scrotal application of a composition for the treatment of hypogonadism |
| 07/04/2002 | WO2002051417A1 Thermofomable solid pharmaceutical composition for controlled release of trimetazidine |
| 07/04/2002 | WO2002051414A1 Medicinal compositions for oral use |
| 07/04/2002 | WO2002051411A1 Famotidine injections |
| 07/04/2002 | WO2002051407A1 Thermoformable solid pharmaceutical composition for controlled release of perindopril |
| 07/04/2002 | WO2002051403A1 Compositions of stable t3 and methods of use thereof |
| 07/04/2002 | WO2002051402A1 Controlled release formulation of divalproex sodium |
| 07/04/2002 | WO2002051401A2 Controlled release formulations of divalproex sodium |
| 07/04/2002 | WO2002051400A2 Solid dosage forms of divalproex sodium |
| 07/04/2002 | WO2002051399A2 Divalproex sodium dosage forms and a process for their production |
| 07/04/2002 | WO2002051392A1 Chewing gums and related products that provide breath freshening characteristics |
| 07/04/2002 | WO2002051391A2 Process for the preparation of medicated gums |
| 07/04/2002 | WO2002051390A2 Amphiphilic lipid nanoparticles for peptide and/or protein incorporation |
| 07/04/2002 | WO2002051389A2 Aerogel powder comprising therapeutic agents |
| 07/04/2002 | WO2002051388A2 Treatment of inoperable tumors by stereotactic injection of microspheres |
| 07/04/2002 | WO2002051387A1 Thermoformable solid pharmaceutical composition for controlled release of ivabradine |
| 07/04/2002 | WO2002051386A2 Lipid microparticles by cryogenic micronization |
| 07/04/2002 | WO2002051385A1 Solid dispersions of nitrate active principles |
| 07/04/2002 | WO2002051384A1 Method of stabilizing suspension and stabilized suspension |
| 07/04/2002 | WO2002051383A2 Controlled release of anti-arrhythmic agents from a biodegradable polyethylene oxide hydrogel for local application to the heart |
| 07/04/2002 | WO2002051382A2 Ph-sensitive mucoadhesive film-forming gels and wax-film composites |